Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3097059rdf:typepubmed:Citationlld:pubmed
pubmed-article:3097059lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0040300lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0020663lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0037668lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0017725lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0597879lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0332240lld:lifeskim
pubmed-article:3097059lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:3097059pubmed:issue1lld:pubmed
pubmed-article:3097059pubmed:dateCreated1987-1-16lld:pubmed
pubmed-article:3097059pubmed:abstractTextUsing a specific and sensitive RIA for GH-releasing hormone (GHRH), we examined the effect of oral administration of 75 g glucose on peripheral plasma GHRH-like immunoreactivity (GHRH-LI) in normal subjects (n = 12) and patients with idiopathic GH deficiency (IGHD) (n = 6). The normal subjects had two peaks of plasma GHRH-LI after oral glucose administration. The initial peak GHRH-LI levels occurred 30-150 min after glucose ingestion and corresponded to an increase in blood glucose. The increment in plasma GHRH-LI levels 30 min after glucose ingestion [7.4 +/- 2.4 (+/- SEM) pg/ml] was significantly higher (P less than 0.05) than that during a control study. Second peaks in plasma GHRH-LI occurred 3.5-6 h after glucose ingestion, and the mean increment 5 h after glucose ingestion was 9.4 +/- 2.4 pg/ml. This second rise of plasma GHRH-LI coincided with a significant increase in plasma GH after reactive hypoglycemia. This second GHRH-LI peak and the rise of plasma GH after hypoglycemia were absent in patients with IGHD, whereas the first peak of plasma GHRH-LI appeared shortly after glucose ingestion in these patients as well as in normal subjects. In addition, hypoglycemia produced by iv injection of regular insulin (0.1 U/kg) was not accompanied by increases in plasma GHRH-LI and GH levels in patients with IGHD, whereas insulin-induced hypoglycemia resulted in significant elevations of both plasma GHRH-LI and GH levels in normal subjects. These findings suggest that peripheral plasma GHRH-LI is derived from the hypothalamus as well as from an extrahypothalamic source(s); extrahypothalamic GHRH is released shortly after glucose ingestion; and secretion of GHRH from the hypothalamus is stimulated by hypoglycemia.lld:pubmed
pubmed-article:3097059pubmed:languageenglld:pubmed
pubmed-article:3097059pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3097059pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3097059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3097059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3097059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3097059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3097059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3097059pubmed:statusMEDLINElld:pubmed
pubmed-article:3097059pubmed:monthJanlld:pubmed
pubmed-article:3097059pubmed:issn0021-972Xlld:pubmed
pubmed-article:3097059pubmed:authorpubmed-author:SatoMMlld:pubmed
pubmed-article:3097059pubmed:authorpubmed-author:FujitaTTlld:pubmed
pubmed-article:3097059pubmed:authorpubmed-author:ChiharaKKlld:pubmed
pubmed-article:3097059pubmed:authorpubmed-author:KitaTTlld:pubmed
pubmed-article:3097059pubmed:authorpubmed-author:KashiiCClld:pubmed
pubmed-article:3097059pubmed:authorpubmed-author:KadowakiSSlld:pubmed
pubmed-article:3097059pubmed:authorpubmed-author:OkimuraYYlld:pubmed
pubmed-article:3097059pubmed:issnTypePrintlld:pubmed
pubmed-article:3097059pubmed:volume64lld:pubmed
pubmed-article:3097059pubmed:ownerNLMlld:pubmed
pubmed-article:3097059pubmed:authorsCompleteYlld:pubmed
pubmed-article:3097059pubmed:pagination92-7lld:pubmed
pubmed-article:3097059pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:meshHeadingpubmed-meshheading:3097059-...lld:pubmed
pubmed-article:3097059pubmed:year1987lld:pubmed
pubmed-article:3097059pubmed:articleTitleEffect of oral glucose administration on plasma growth hormone-releasing hormone (GHRH)-like immunoreactivity levels in normal subjects and patients with idiopathic GH deficiency: evidence that GHRH is released not only from the hypothalamus but also from extrahypothalamic tissue.lld:pubmed
pubmed-article:3097059pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3097059pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3097059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3097059lld:pubmed